3-iodobenzylguanidine has been researched along with Dizziness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heavner, MG; Krane, LS; Mirzazadeh, M; Winters, SM | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Dizziness
| Article | Year |
|---|---|
Pheochromocytoma diagnosed pathologically with previous negative serum markers.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers, Tumor; Body Mass Index; Catecholamines; Dizziness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pheochromocytoma; Prognosis; Retrospective Studies; Vertigo; Young Adult | 2015 |